www.bostonherald.com
2 months agoWhy COVID patients who could most benefit from Paxlovid still aren't getting it
The high cost of Paxlovid is a barrier to access for many patients.
Low awareness among patients and doctors about Paxlovid's benefits and application process. [ more ]